Completed
Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
NCT05795400
- Conditions
- Amyloid Cardiomyopathy, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +20 more
- Locations
-
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Moscow, Russia